Welcome to our dedicated page for AvePoint news (Ticker: $AVPT), a resource for investors and traders seeking the latest updates and insights on AvePoint stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AvePoint's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AvePoint's position in the market.
AvePoint (NASDAQ: AVPT) reported strong financial results for the first quarter of 2024, with SaaS revenue reaching $51.3 million, a 44% year-over-year growth. Total revenue was $74.5 million, up 25% from the same period last year. The company's gross profit increased to $54.1 million, and non-GAAP operating income was $6.6 million. AvePoint also raised its full-year outlook for total ARR, total revenues, and non-GAAP operating income. The company's cash, cash equivalents, and short-term investments stood at $219.3 million as of March 31, 2024.
AvePoint (Nasdaq: AVPT) will participate in upcoming investor conferences to present their advanced platform optimizing SaaS operations and secure collaboration. The company's executive team will attend various conferences, providing live and archived webcasts for investors.